MedPath

The study of small dose chemotherapy after surgery not fit for radiotherapy in recurrent head and neck cancers patients.

Phase 2
Conditions
Health Condition 1: null- recurrent head and neck cancers patients post R0 salvage surgical resection who are ineligible for re-irradiation.
Registration Number
CTRI/2016/04/006872
Lead Sponsor
Tata Memorial Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
400
Inclusion Criteria

1.Patients with recurrenthead and neck cancers with primary in oral cavity, oropharynx, larynx or hypopharynx who have undergone complete salvage resection ( R0 resection)

2.Ineligibile for re-irradiation in target region after assesement in joint clinic.

3.Age >=18 years

4.ECOG performance status PS 0-2

5.Adequate bone marrow function (Haemoglobin > 8 0g/L, platelets > 100 x 109/L, ANC > 1.5 x 109/L)

6.Adequate liver function (ALT/AST < 1.5 x ULN, serum bilirubin < 2mg/dl)

7.Adequate renal function (creatinine clearance > 50 ml/min)

8.Adequate cardiac function (LVEF >40%)

9.Study treatment both planned and able to start within 28 days of enrollment

10.Willing and able to comply with all study requirements, including treatment (able to swallow tablets), able to be followed up at regular intervals and/or nature of required assessments (e.g. able to have IV contrast if this is required for tumour assessments)

11.Signed, written informed consent for main study and tissue banking.

Exclusion Criteria

1.QTc prolongation (QTc B prolonged more than 450 millisecond)

2.Any significant active infection, including chronic active hepatitis B, hepatitis C, or HIV. for these is not mandatory unless clinically indicated. Participants with known Hepatitis B/C infection will be allowed to participate providing evidence of viral suppression has been documented and the patient remains on appropriate anti-viral therapy.

3.Concurrent illness, including severe infection that may jeopardize the ability of the patient to undergo the procedures outlined in this protocol with reasonable safety; Serious medical (e.g. Diabetes Mellitus, Hypertension, COPD ,active Tuberculosis or psychiatric conditions that might limit the ability of the patient to comply with the protocol.

4.Presence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule, including alcohol dependence or drug abuse.

5.Pregnancy, lactation, or inadequate contraception. Women must be post menopausal, infertile, or use a reliable means of contraception. Women of childbearing potential must have a negative pregnancy test done within 7 days prior to registration. Men must have been surgically sterilised or use a (double if required) barrier method of contraception.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath